Dr. Leslie M. Randall

Dr. Leslie M. Randall, MD, is a nationally distinguished gynecologic oncologist renowned for her expertise in the treatment of ovarian, endometrial, and other gynecologic malignancies. She currently serves as the Director of Gynecologic Oncology at the Inova Schar Cancer Institute, where she leads a comprehensive program dedicated to advancing the care of women with complex gynecologic cancers. Dr. Randall earned her medical degree from the University of Louisville School of Medicine, followed by residency in Obstetrics and Gynecology and fellowship training in Gynecologic Oncology at the University of California, Irvine. She is board-certified in both Obstetrics and Gynecology and Gynecologic Oncology.

Dr. Randall’s career has been defined by her commitment to innovation in cancer therapeutics and precision medicine. Her research has focused on developing and evaluating novel targeted therapies and immunotherapies, particularly for patients with recurrent or resistant ovarian cancer. She has served as principal investigator for numerous national clinical trials and contributed to landmark studies that have influenced clinical practice and improved survival outcomes. Her scholarly work is widely published in leading oncology journals, and her clinical research has played a pivotal role in the evolution of gynecologic cancer treatment.

Beyond her clinical and research contributions, Dr. Randall is a respected educator and leader in the oncology community. She holds leadership positions in national cooperative groups such as NRG Oncology and is an active member of the Society of Gynecologic Oncology. She is deeply committed to mentoring the next generation of gynecologic oncologists and fostering interdisciplinary collaboration. Through her dedication to patient-centered care, clinical excellence, and groundbreaking research, Dr. Randall continues to shape the future of gynecologic oncology and empower women facing cancer with hope and advanced treatment options.